Who owns PLUS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Plus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Plus Therapeutics stock

Who bought or sold PLUS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 2.3M $1.2M 58% Dec 2025
 View chart
UBS Group 876k $448k 40% Dec 2025
 View chart
Geode Capital Management 813k $556k 1489% Sep 2025
 View chart
BlackRock 469k $321k 6644% Sep 2025
 View chart
State Street Corporation 342k $234k 100% Sep 2025
 View chart
Northern Trust 266k $182k 100% Sep 2025
 View chart
Scientech Research 147k $100k 100% Sep 2025
 View chart
Susquehanna International 67k $46k 100% Sep 2025
 View chart
Mercer Global Advisors 29k $20k 100% Sep 2025
 View chart
Dagco 26k $13k 0% Dec 2025
 View chart
Kestra Advisory Services 26k $18k 100% Sep 2025
 View chart
Ashton Thomas Private Wealth 25k $13k 100% Dec 2025
 View chart
Cambridge Investment Research Advisors 14k $7.0k 28% Dec 2025
 View chart
Cubist Systematic Strategies 12k $8.0k 14% Sep 2025
 View chart
Two Sigma Securities 11k $7.6k 100% Sep 2025
 View chart
Tower Research Capital 3.5k $2.4k -42% Sep 2025
 View chart
SBI Securities 3.3k $2.3k 48% Sep 2025
 View chart
Advisor Group Holdings 133.00 $58.998800 0% Sep 2025
 View chart
Wells Fargo & Company 53.00 $35.997600 -85% Sep 2025
 View chart
Barclays 2.00 $1.000000 -98% Sep 2025
 View chart
Group One Trading 1.00 $1.000000 100% Sep 2025
 View chart
Danske Bank A/s 1.00 $1.000000 0% Dec 2025
 View chart

Who sold out of Plus Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Altium Capital Management Sep 2025 919k $628M
Jane Street Jun 2025 118k $41k
Millennium Management Jun 2025 24k $8.4k
Jones Financial Companies, L.L Jun 2025 26.00 $8.000200